JPMorgan Chase & Co is a financial holding company, which engages in providing financial and investment banking services. has a consensus rating of “Moderate Buy” and an average price target of $155.00. According to data from, JPMorgan Chase & Co. Six investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. from $160.00 to $172.00 in a research note on Friday, April 14th. Finally, The Goldman Sachs Group raised their target price on shares of JPMorgan Chase & Co. from $153.00 to $157.00 and gave the stock an “overweight” rating in a research note on Monday, April 17th. Morgan Stanley increased their price target on shares of JPMorgan Chase & Co. in a research note on Thursday, March 16th. started coverage on shares of JPMorgan Chase & Co. from $147.00 to $151.00 and gave the stock an “overweight” rating in a research note on Monday, April 17th. Piper Sandler increased their price target on shares of JPMorgan Chase & Co. from $157.00 to $146.00 and set an “outperform” rating on the stock in a research note on Wednesday, April 5th. Evercore ISI cut their price target on shares of JPMorgan Chase & Co. Wall Street Analysts Forecast GrowthĪ number of equities analysts have weighed in on JPM shares. JPMorgan Chase & Co.’s dividend payout ratio is presently 29.52%. The ex-dividend date of this dividend was Wednesday, April 5th. This represents a $4.00 dividend on an annualized basis and a dividend yield of 2.93%. Investors of record on Thursday, April 6th were given a dividend of $1.00 per share. The firm also recently disclosed a quarterly dividend, which was paid on Sunday, April 30th. will post 14.33 earnings per share for the current fiscal year. As a group, research analysts anticipate that JPMorgan Chase & Co. During the same period last year, the business earned $2.63 EPS. The firm’s revenue for the quarter was up 24.8% compared to the same quarter last year. had a net margin of 23.73% and a return on equity of 16.02%. The company had revenue of $38.35 billion during the quarter, compared to analyst estimates of $35.77 billion. The financial services provider reported $4.10 earnings per share for the quarter, topping the consensus estimate of $3.41 by $0.69. ( NYSE:JPM – Get Rating) last announced its quarterly earnings data on Friday, April 14th. 67.89% of the stock is currently owned by institutional investors and hedge funds. BerganKDV Wealth Management LLC now owns 35,995 shares of the financial services provider’s stock worth $3,762,000 after purchasing an additional 2,079 shares during the period. Finally, BerganKDV Wealth Management LLC raised its stake in JPMorgan Chase & Co. now owns 24,284 shares of the financial services provider’s stock worth $3,256,000 after purchasing an additional 149 shares during the period. Ballentine Partners LLC now owns 51,929 shares of the financial services provider’s stock worth $5,427,000 after purchasing an additional 5,719 shares during the period. Ballentine Partners LLC raised its stake in JPMorgan Chase & Co. Leisure Capital Management now owns 22,736 shares of the financial services provider’s stock worth $2,376,000 after purchasing an additional 600 shares during the period. Leisure Capital Management raised its stake in JPMorgan Chase & Co. Aptus Capital Advisors LLC now owns 153,622 shares of the financial services provider’s stock worth $16,054,000 after acquiring an additional 15,607 shares during the last quarter. Aptus Capital Advisors LLC boosted its position in JPMorgan Chase & Co. Several other large investors have also modified their holdings of the business. worth $634,184,000 at the end of the most recent quarter. owned approximately 0.16% of JPMorgan Chase & Co. The fund owned 4,729,191 shares of the financial services provider’s stock after purchasing an additional 323,779 shares during the quarter. ( NYSE:JPM – Get Rating) by 7.3% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). ![]() grew its holdings in JPMorgan Chase & Co.
0 Comments
Leave a Reply. |